Liver function determined via albumin, bilirubin, prothrombin time, and platelet count was statistically better for people with MASLD HCC, and alpha‐fetoprotein levels at the time of presentation with HCC were comparable between groups. This evidence concerns the gene AFP and hepatocellular carcinoma.